title: Chronic HO-1 induction with cobalt protoporphyrin (CoPP) treatment increases oxygen consumption, activity, heat production and lowers body weight in obese melanocortin-4 receptor-deficient mice.
abstract: OBJECTIVE
  Heme oxygenase-1 induction (HO-1) elicits chronic weight loss in several rodent models of obesity. Despite these findings, the mechanism by which HO-1 induction reduces body weight is unclear. Chronic HO-1 induction does not alter food intake, suggesting other mechanisms such as increases in metabolism and activity may be responsible for the observed reduction of body weight. In this study, we investigated the mechanism of weight loss elicited by chronic HO-1 induction in a model of genetic obesity due to melanocortin-4 receptor (MC4R) deficiency.
  
  
  METHODS
  Experiments were performed on loxTB MC4R-deficient mice as well as lean controls. Mice were administered cobalt protoporphyrin (CoPP, 5 mg kg(-1)), an inducer of HO-1, once weekly, from 4 to 23 weeks of age. Body weights were measured weekly and fasted blood glucose and insulin, as well as food intake were determined at 18 weeks of age. Oxygen consumption (VO(2)), CO(2) production (VCO(2)), activity and body heat production were measured at 20 weeks of age.
  
  
  RESULTS
  Chronic CoPP treatment resulted in a significant decrease in body weight from 5 weeks on in loxTB mice. Chronic CoPP treatment resulted in a significant decrease in fasted blood glucose levels, plasma insulin and a significant increase in plasma adiponectin levels in MC4R-deficient mice. Chronic CoPP treatment increased VO(2) (47 ± 4 vs 38 ± 3 ml kg(-1) per min, P<0.05) and VCO(2) (44 ± 7 vs 34 ± 4 ml kg(-1) per min, P<0.05) in treated vs non-treated, MC4R-deficient mice (n=4). Heat production (10%) and activity (18%) were also significantly (P<0.05) increased in CoPP-treated MC4R-deficient mice.
  
  
  CONCLUSIONS
  Our results suggest that chronic HO-1 induction with CoPP induction elicits weight loss by increasing metabolism and activity by an MC4R-independent pathway.
authors.affiliation: Department of Physiology & Biophysics, Center for Excellence in Cardiovascular-Renal Research, University of Mississippi Medical Center, Jackson, MS 39216, USA.
authors.forename: E
authors.initials: E
authors.lastname: Csongradi
authors.forename: J M
authors.initials: JM
authors.lastname: Docarmo
authors.forename: J H
authors.initials: JH
authors.lastname: Dubinion
authors.forename: T
authors.initials: T
authors.lastname: Vera
authors.forename: D E
authors.initials: DE
authors.lastname: Stec
mesh_terms: D000818:Animals; D015153:Blotting, Western; D001835:Body Weight / Q000187:drug effects*; D051547:Heme Oxygenase-1 / Q000187:drug effects* / Q000378:metabolism; D008297:Male; D051379:Mice; D008820:Mice, Obese; D009043:Motor Activity / Q000187:drug effects*; D010101:Oxygen Consumption / Q000187:drug effects*; D011524:Protoporphyrins / Q000494:pharmacology*; D044105:Receptor, Melanocortin, Type 4 / Q000172:deficiency / Q000187:drug effects*; D022722:Thermogenesis / Q000187:drug effects*; D015431:Weight Loss / Q000187:drug effects*
chemical_list: D011524:Protoporphyrins; D044105:Receptor, Melanocortin, Type 4; C007095:cobaltiprotoporphyrin; D051547:Heme Oxygenase-1